193 related articles for article (PubMed ID: 31863456)
1. Identification of diagnostic metabolic signatures in clear cell renal cell carcinoma using mass spectrometry imaging.
Vijayalakshmi K; Shankar V; Bain RM; Nolley R; Sonn GA; Kao CS; Zhao H; Tibshirani R; Zare RN; Brooks JD
Int J Cancer; 2020 Jul; 147(1):256-265. PubMed ID: 31863456
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing Renal Cell Carcinoma From Normal Kidney Tissue Using Mass Spectrometry Imaging Combined With Machine Learning.
Shankar V; Vijayalakshmi K; Nolley R; Sonn GA; Kao CS; Zhao H; Wen R; Eberlin LS; Tibshirani R; Zare RN; Brooks JD
JCO Precis Oncol; 2023 Jun; 7():e2200668. PubMed ID: 37285559
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging.
Eberlin LS; Margulis K; Planell-Mendez I; Zare RN; Tibshirani R; Longacre TA; Jalali M; Norton JA; Poultsides GA
PLoS Med; 2016 Aug; 13(8):e1002108. PubMed ID: 27575375
[TBL] [Abstract][Full Text] [Related]
4. Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.
Alfaro CM; Jarmusch AK; Pirro V; Kerian KS; Masterson TA; Cheng L; Cooks RG
Anal Bioanal Chem; 2016 Aug; 408(20):5407-14. PubMed ID: 27206411
[TBL] [Abstract][Full Text] [Related]
5. Molecular assessment of surgical-resection margins of gastric cancer by mass-spectrometric imaging.
Eberlin LS; Tibshirani RJ; Zhang J; Longacre TA; Berry GJ; Bingham DB; Norton JA; Zare RN; Poultsides GA
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2436-41. PubMed ID: 24550265
[TBL] [Abstract][Full Text] [Related]
6. In situ DESI-MSI lipidomic profiles of mucosal margin of oral squamous cell carcinoma.
Yang X; Song X; Zhang X; Shankar V; Wang S; Yang Y; Chen S; Zhang L; Ni Y; Zare RN; Hu Q
EBioMedicine; 2021 Aug; 70():103529. PubMed ID: 34391097
[TBL] [Abstract][Full Text] [Related]
7. Multivariate statistical differentiation of renal cell carcinomas based on lipidomic analysis by ambient ionization imaging mass spectrometry.
Dill AL; Eberlin LS; Zheng C; Costa AB; Ifa DR; Cheng L; Masterson TA; Koch MO; Vitek O; Cooks RG
Anal Bioanal Chem; 2010 Dec; 398(7-8):2969-78. PubMed ID: 20953777
[TBL] [Abstract][Full Text] [Related]
8. Desorption electrospray ionization mass spectrometry imaging (DESI-MSI) in disease diagnosis: an overview.
Kumar BS
Anal Methods; 2023 Aug; 15(31):3768-3784. PubMed ID: 37503728
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry Imaging Enables Discrimination of Renal Oncocytoma from Renal Cell Cancer Subtypes and Normal Kidney Tissues.
Zhang J; Li SQ; Lin JQ; Yu W; Eberlin LS
Cancer Res; 2020 Feb; 80(4):689-698. PubMed ID: 31843980
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids.
Banerjee S; Zare RN; Tibshirani RJ; Kunder CA; Nolley R; Fan R; Brooks JD; Sonn GA
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3334-3339. PubMed ID: 28292895
[TBL] [Abstract][Full Text] [Related]
11. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities.
Erlmeier F; Sun N; Shen J; Feuchtinger A; Buck A; Prade VM; Kunzke T; Schraml P; Moch H; Autenrieth M; Weichert W; Hartmann A; Walch A
Oncology; 2023; 101(2):126-133. PubMed ID: 36198279
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging.
Margulis K; Chiou AS; Aasi SZ; Tibshirani RJ; Tang JY; Zare RN
Proc Natl Acad Sci U S A; 2018 Jun; 115(25):6347-6352. PubMed ID: 29866838
[TBL] [Abstract][Full Text] [Related]
13. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of human peripheral nerves using desorption electrospray ionization mass spectrometry imaging.
Tomalty D; Giovannetti O; Velikonja L; Munday J; Kaufmann M; Iaboni N; Jamzad A; Rubino R; Fichtinger G; Mousavi P; Nicol CJB; Rudan JF; Adams MA
J Anat; 2023 Nov; 243(5):758-769. PubMed ID: 37264225
[TBL] [Abstract][Full Text] [Related]
16. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma.
Ding J; Xing Z; Jiang Z; Chen J; Pan L; Qiu J; Xing W
Eur J Radiol; 2018 Jun; 103():51-56. PubMed ID: 29803385
[TBL] [Abstract][Full Text] [Related]
17. Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry.
Drake RR; McDowell C; West C; David F; Powers TW; Nowling T; Bruner E; Mehta AS; Angel PM; Marlow LA; Tun HW; Copland JA
J Mass Spectrom; 2020 Apr; 55(4):e4490. PubMed ID: 31860772
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Metabolic Signature for Cancer Diagnosis Using Desorption Electrospray Ionization Mass Spectrometric Imaging.
Banerjee S; Manna SK
Methods Mol Biol; 2019; 1928():275-297. PubMed ID: 30725461
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging.
Bensussan AV; Lin J; Guo C; Katz R; Krishnamurthy S; Cressman E; Eberlin LS
Clin Chem; 2020 Nov; 66(11):1424-1433. PubMed ID: 33141910
[TBL] [Abstract][Full Text] [Related]
20. Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma.
Saito K; Arai E; Maekawa K; Ishikawa M; Fujimoto H; Taguchi R; Matsumoto K; Kanai Y; Saito Y
Sci Rep; 2016 Jun; 6():28932. PubMed ID: 27357243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
